NFKB1 and diabetes mellitus: Calcium dobesilate (CaD) is used to treat microvascular complications of diabetes, which ameliorates hemodynamics, and restrains inflammatory molecules and renal fibrosis by reducing oxidative stress and the activation of MAPK and NF-κB [12, 13].